| abstract |
The present invention provides compositions and methods for treating glaucoma, methods for diagnosing glaucoma, and methods for identifying factors that may be useful in the treatment of glaucoma. More specifically, the present invention describes the use of factors that modulate the expression of serum amyloid A. In a threshold aspect, a method for treating glaucoma is provided. The method includes administering to a patient in need of glaucoma a therapeutically effective amount of a composition that interacts with a gene encoding serum amyloid A protein (SAA). This factor, which acts, regulates SAA expression. |